VFA
CLVS

Virtus Fund Advisers’s Clovis Oncology, Inc. CLVS Stock Holding History

Virtus Fund Advisers’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.14M Buy
16,747
+14,208
+560% +$993K 0.01% 277
2017
Q3 		$209K Sell
2,539
-158
-6% -$12.5K ﹤0.01% 368
2017
Q2 		$258K Buy
+2,697
New +$165K ﹤0.01% 380
2014
Q3 		– Sell
-2,105
Closed -$87K – 2098
2014
Q2 		$87K Buy
+2,105
New +$108K ﹤0.01% 1500

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Virtus Fund Advisers's CLVS Position: Q4 2017 in Review

Virtus Fund Advisers increased its Clovis Oncology, Inc. (CLVS) stake by 560% in Q4 2017, buying an estimated $993K and bringing the position to 16,747 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #277.

Virtus Fund Advisers first reported a position in CLVS in Q2 2014 and has held it in 4 quarters since. 247 funds tracked by Wall St. Rank hold CLVS as of Q4 2017.

  • Virtus Fund Advisers held 16,747 shares of Clovis Oncology, Inc. worth $1.14M as of Q4 2017.
  • Virtus Fund Advisers bought 14,208 Clovis Oncology, Inc. shares in Q4 2017, an estimated $993K.
  • Clovis Oncology, Inc. made up 0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #277 holding.
  • Virtus Fund Advisers first reported a position in Clovis Oncology, Inc. in Q2 2014 and has held it in 4 quarters since.
  • 247 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.